Artykuły udostępnione publicznie: - Simon LangdonWięcej informacji
Niedostępne w żadnym miejscu: 7
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
C Ward, SP Langdon, P Mullen, AL Harris, DJ Harrison, CT Supuran, ...
Cancer treatment reviews 39 (2), 171-179, 2013
Upoważnienia: Cancer Research UK, UK Medical Research Council
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer
G Walker, K MacLeod, ARW Williams, DA Cameron, JF Smyth, ...
Gynecologic oncology 106 (3), 461-468, 2007
Upoważnienia: Cancer Research UK
The role of tandem duplicator phenotype in tumour evolution in high‐grade serous ovarian cancer
CKY Ng, SL Cooke, K Howe, S Newman, J Xian, J Temple, EM Batty, ...
The Journal of pathology 226 (5), 703-712, 2012
Upoważnienia: Cancer Research UK
Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models
TA Gray, NJ MacLaine, CO Michie, P Bouchalova, E Murray, J Howie, ...
Journal of immunological methods 378 (1-2), 20-32, 2012
Upoważnienia: Cancer Research UK
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapy
D Faratian, IH Um, DS Wilson, P Mullen, SP Langdon, DJ Harrison
European Journal of Cancer 47 (9), 1420-1431, 2011
Upoważnienia: Cancer Research UK
Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow
IH Kunkler, C Ward, SP Langdon
The Breast 24, S114-S119, 2015
Upoważnienia: UK Engineering and Physical Sciences Research Council
Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment
C Ward, J Meehan, M Gray, IH Kunkler, SP Langdon, A Murray, D Argyle
Three Dimensional Human Organotypic Models for Biomedical Research, 225-246, 2021
Upoważnienia: UK Engineering and Physical Sciences Research Council
Dostępne w jakimś miejscu: 38
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system
A Koussounadis, SP Langdon, IH Um, DJ Harrison, VA Smith
Scientific reports 5 (1), 10775, 2015
Upoważnienia: Wellcome Trust, European Commission
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15, 1-37, 2013
Upoważnienia: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma
W Sakai, EM Swisher, C Jacquemont, KV Chandramohan, FJ Couch, ...
Cancer research 69 (16), 6381-6386, 2009
Upoważnienia: US National Institutes of Health
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients
JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ...
Clinical Cancer Research 13 (12), 3617-3622, 2007
Upoważnienia: Cancer Research UK
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ...
Oncogene 29 (35), 4905-4913, 2010
Upoważnienia: Cancer Research UK
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models
C Xintaropoulou, C Ward, A Wise, H Marston, A Turnbull, SP Langdon
Oncotarget 6 (28), 25677, 2015
Upoważnienia: UK Medical Research Council
Implantable biosensors and their contribution to the future of precision medicine
M Gray, J Meehan, C Ward, SP Langdon, IH Kunkler, A Murray, D Argyle
The Veterinary Journal 239, 21-29, 2018
Upoważnienia: UK Engineering and Physical Sciences Research Council
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers
R Hrstka, R Nenutil, A Fourtouna, MM Maslon, C Naughton, S Langdon, ...
Oncogene 29 (34), 4838-4847, 2010
Upoważnienia: Cancer Research UK
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
EO Pettersen, P Ebbesen, RG Gieling, KJ Williams, L Dubois, P Lambin, ...
Journal of enzyme inhibition and medicinal chemistry 30 (5), 689-721, 2015
Upoważnienia: Cancer Research UK, UK Medical Research Council
The impact of tumour pH on cancer progression: strategies for clinical intervention
C Ward, J Meehan, ME Gray, AF Murray, DJ Argyle, IH Kunkler, ...
Exploration of Targeted Anti-tumor Therapy 1 (2), 71, 2020
Upoważnienia: UK Engineering and Physical Sciences Research Council
Development and characterisation of acquired radioresistant breast cancer cell lines
M Gray, AK Turnbull, C Ward, J Meehan, C Martínez-Pérez, M Bonello, ...
Radiation oncology 14, 1-19, 2019
Upoważnienia: UK Engineering and Physical Sciences Research Council
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer
C Martinez-Perez, C Ward, G Cook, P Mullen, D McPhail, DJ Harrison, ...
Biochemical Society Transactions 42 (4), 1017-1023, 2014
Upoważnienia: UK Biotechnology and Biological Sciences Research Council
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models
C Ward, J Meehan, P Mullen, C Supuran, JM Dixon, JS Thomas, ...
Oncotarget 6 (28), 24856, 2015
Upoważnienia: UK Medical Research Council
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy